Asthma Clinical Trials in Philadelphia

Showing 281-300 of 314 trials

Study Evaluating the Safety and Efficacy of MN-221 as an Adjunct to Standard Therapy in Subjects Experiencing an Acute Exacerbation of Asthma

NCT00838591

The objective of this clinical study is to examine the safety and effectiveness of intravenous MN-221 compared to placebo when administered as an adjunct to standard therapy in subjects experiencing an acute exacerbation of asthma.

Asthma

MediciNova176 participantsStarted Mar 2009

Loma Linda, California, United States • San Diego, California, United States • San Diego, California, United States +12 more locations

COMPLETEDPhase 4< 1 mile

Efficacy of Omalizumab in Adults (18-60 Years of Age) With Moderate-Severe, Persistent Allergic Asthma, Despite Receiving Inhaled Corticosteroids and Long Acting Beta-agonists

NCT00670930

This study aims to investigate the effect of omalizumab on the number of tissue eosinophils and other markers of airway inflammation and remodeling, including thickness of the lamina reticularis, in moderate to severe asthmatics with persistent symptoms and evidence of airway inflammation despite treatment with inhaled corticosteroids and long acting beta-agonists. This study will also investigate the correlation between systemic and pulmonary inflammation, and the correlation between clinical outcomes and changes within the tissue, to assist in the future identification of patients with tissue eosinophilia and their response to treatment, without the need for invasive bronchoscopy.

Allergic Asthma

Novartis Pharmaceuticals36 participantsStarted Apr 2008

Denver, Colorado, United States • St Louis, Missouri, United States • Durham, North Carolina, United States +13 more locations

Study Evaluating the Safety and Efficacy of MN-221 as an Adjunct to Standard Therapy in Subjects Experiencing an Acute Exacerbation of Asthma

Efficacy of Omalizumab in Adults (18-60 Years of Age) With Moderate-Severe, Persistent Allergic Asthma, Despite Receiving Inhaled Corticosteroids and Long Acting Beta-agonists

Asthma Trials in Other Cities

Study of Acid Reflux in Asthma

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Reliability of a Top Mount Actuation Indicator With Levalbuterol MDI in Adult and Pediatric Subjects With Asthma or COPD

Combivent® CFC Metered Dose Inhaler (MDI) in Moderate to Severe Asthma

A Study in Asthmatic Children (6 to <12 Yrs) Comparing Single Doses of Formoterol and Foradil® Evaluating Efficacy

Investigation of Efficacy, Safety and Tolerability of Once and Twice Daily Doses of AZD1981 in Asthmatic Patients

Effect of a Community-based Nursing Intervention on Mortality in Chronically Ill Older Adults

High Flow Nasal Cannula Versus Nasal Continuous Positive Airway Pressure

A Placebo and Active Controlled Study of ONO-6950 in Asthmatic Patients

Study of Daclizumab in Patients With Chronic, Persistent Asthma

Pilot Study in Patients With Symptomatic Steroid-Naive Asthma

Sofia RSV FIA Field Study

Calfactant for Direct Acute Respiratory Distress Syndrome

A Study to Assess Selected Biomarkers in Subjects Requiring Daily Inhaled Corticosteroids for Persistent Asthma

Safety and Tolerability Study to Evaluate MEDI-534 in Children 6 to < 24 Months of Age

Costs & Outcomes of Hospitalization/Treatment With Levalbuterol & Albuterol in Asthma or Chronic Obstructive Pulmonary Disease (COPD) Subjects

Safety and Tolerability Study of Levalbuterol HFA Compared to Racemic Albuterol HFA in Subjects With Asthma

One Month Dose Response Study of AZD1981 in Asthma Patients Uncontrolled on Inhaled Steroids

Other Conditions in Philadelphia